Literature DB >> 12217606

Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection.

Gabriella Pár1, Daniel Rukavina, Eckhard R Podack, Margit Horányi, Júlia Szekeres-Barthó, Géza Hegedüs, Mária Paál, László Szereday, Gyula Mózsik, Alajos Pár.   

Abstract

BACKGROUND/AIMS: As chronic hepatitis C virus (HCV) infection is associated with impaired natural killer (NK) cell cytotoxicity, we examined the phenotypes and perforin expression of peripheral blood lymphocytes, as well as the effect of interferon-alpha2b (IFN-alpha2b) therapy.
METHODS: Thirty-three patients had chronic hepatitis C, and of them 12 had been on IFN-alpha2b treatment. Eleven individuals had been treated earlier with IFN-alpha2b and completely cured, and eight were HCV carriers with persistently normal serum alanine aminotransferase. Three-colour flow cytometry was used to measure the percentage of CD3(+/-)CD8+, CD3+CD4+, gammadeltaTcR+, Vdelta2 TcR+, Vgamma9 TcR+, Vdelta1 TcR+, CD3-CD16+, CD3-CD56+, CD19+ and perforin-positive cells. NK cell activity was assessed by single cell cytotoxic and flow cytometric assay.
RESULTS: Patients with chronic hepatitis C showed an impaired NK cytotoxicity, decreased percentage of CD3-negative-CD8dim-positive (NK subtype) and Vgamma9/Vdelta2 TcR+ as well as perforin-positive T lymphocytes, compared to controls and to those who were cured from HCV infection. IFN-alpha2b increased NK cell cytotoxicity and the percentage of perforin-positive lymphocytes.
CONCLUSIONS: Our findings suggest that in chronic HCV infection a decreased percentage of CD3(-)CD8+, Vgamma9/Vdelta2 TcR+ and perforin-positive T cells and simultaneous decreased peripheral NK activity may contribute to the impaired cellular immune response and the chronicity of the disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217606     DOI: 10.1016/s0168-8278(02)00218-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  39 in total

1.  Chronic fatigue syndrome is associated with diminished intracellular perforin.

Authors:  K J Maher; N G Klimas; M A Fletcher
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

2.  CD8+ T-cell dysfunction due to cytolytic granule deficiency in persistent Friend retrovirus infection.

Authors:  Gennadiy Zelinskyy; Shelly J Robertson; Simone Schimmer; Ronald J Messer; Kim J Hasenkrug; Ulf Dittmer
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Non-neutralizing epitopes induce robust hepatitis C virus (HCV)-specific antibody-dependent CD56+ natural killer cell responses in chronic HCV-infected patients.

Authors:  L Long; M Jia; X Fan; H Liang; J Wang; L Zhu; Z Xie; T Shen
Journal:  Clin Exp Immunol       Date:  2017-04-07       Impact factor: 4.330

4.  Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro.

Authors:  Lucy Golden-Mason; Andrea L Cox; Jessica A Randall; Linling Cheng; Hugo R Rosen
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

5.  Immunological changes in different patient populations with chronic hepatitis C virus infection.

Authors:  Laszlo Szereday; Matyas Meggyes; Melinda Halasz; Julia Szekeres-Bartho; Alajos Par; Gabriella Par
Journal:  World J Gastroenterol       Date:  2016-05-28       Impact factor: 5.742

6.  Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines.

Authors:  Damien Sène; Franck Levasseur; Michal Abel; Marion Lambert; Xavier Camous; Céline Hernandez; Véronique Pène; Arielle R Rosenberg; Evelyne Jouvin-Marche; Patrice N Marche; Patrice Cacoub; Sophie Caillat-Zucman
Journal:  PLoS Pathog       Date:  2010-11-11       Impact factor: 6.823

7.  Differentially regulated gene expression associated with hepatitis C virus clearance.

Authors:  Carolyn Z Grimes; Lu-Yu Hwang; Peng Wei; Dimpy P Shah; Kelly A Volcik; Eric L Brown
Journal:  J Gen Virol       Date:  2012-11-14       Impact factor: 3.891

Review 8.  Impairment of innate immune responses in cirrhotic patients and treatment by branched-chain amino acids.

Authors:  Ikuo Nakamura
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

9.  CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection.

Authors:  A W Lin; S A Gonzalez; S Cunningham-Rundles; G Dorante; S Marshall; A Tignor; C Ha; I M Jacobson; A H Talal
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

10.  Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function.

Authors:  Sara J Conry; Kimberly A Milkovich; Nicole L Yonkers; Benigno Rodriguez; Helene B Bernstein; Robert Asaad; Frederick P Heinzel; Magdalena Tary-Lehmann; Michael M Lederman; Donald D Anthony
Journal:  J Virol       Date:  2009-08-19       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.